X0306 4 2017-02-06 false 0001597553 Sage Therapeutics, Inc. SAGE 0001612903 Anderson Thomas C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false See Remarks Stock Option (Right to Buy) 47.70 2017-02-06 4 A false 40000.00 0.00 A 2027-02-06 Common Stock 40000.00 40000.00 D The securities awarded on 2/06/2017 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 20,000 shares of common stock shall vest periodically over the next four years upon the Company achieving certain milestones. Chief Commercial Strategy Officer /s/ Anne Marie Cook, as Attorney-in-Fact for Thomas Anderson 2017-02-08